نتایج جستجو برای: naftopidil
تعداد نتایج: 104 فیلتر نتایج به سال:
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creative-commons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution , and reproduction in any medium, provided the original work is properly cited. In order to find new therapeutic methods and to understand their underlying mechanisms fo...
Naftopidil (NAF) is widely used for the treatment of benign prostatic hyperplasia and prevention of prostate cancer in elderly men. These patients receive a combination of drugs, which involves high risk for drug-drug interaction. NAF exhibits superior efficacy but must be administered at a much higher dosage than other therapeutic drugs. We previously showed that extensive glucuronidation of N...
Objective: Naftopidil (NAF) is a selective alpha1-adrenergic receptor antagonist with nearly 20% bioavailability due to poor aqueous solubility, permeability, and extensive first-pass metabolism. To improve the of NAF, solid lipid nanoparticles (SLN) NAF were prepared. Methods: SLNs prepared using solvent emulsification/evaporation method excipients Compritol 888 ATO Poloxamer 188. Formulation ...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید